Advancing Tarlatamab in SCLC: From Second-Line Approval to Frontline & Combination Strategies

4:00 pm - Thursday 17th September 2026

  • Details to be announced

Speakers:

Anna Farago
Vice President, Early Development Oncology
Amgen Inc.